Late relapse of acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy: Report of two cases

Annals of Hematology

Volumn 83, Issue 7, 2004, Pages 484-486

  Ferrara, Felicetto ^a   Selleri, Carmine ^b   Mele, Giuseppina ^a   Serio, Bianca ^b   Palmieri, Salvatore ^a   Pocali, Barbara ^a   Pane, Fabrizio ^b   Rotoli, Bruno ^b  

^a CARDARELLI HOSPITAL   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Acute promyelocytic leukemia; ATRA; Chemotherapy; Late relapse

Indexed keywords

ANTHRACYCLINE DERIVATIVE; IDARUBICIN; RETINOIC ACID;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; CHROMOSOME ANALYSIS; DOSE RESPONSE; FREQUENCY ANALYSIS; HISTOLOGY; HUMAN; IMMUNOPHENOTYPING; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HUMANS; IDARUBICIN; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; RECURRENCE; REMISSION INDUCTION; SALVAGE THERAPY; TIME FACTORS; TRETINOIN;

EID: 3042856270     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-003-0842-7     Document Type: Article

References (14)

1. Avvisati G, Lo Coco F, Diverio D, Falda M, Ferrara F, Lazzarino M, Russo D, Petti MC, Mandelli F (1996) AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie ematologiche Maligne dell'Adulto (GIMEMA) study. Blood 88:1390-1398
2. Avvisati G, Lo Coco F, Mandelli F (2001) Acute promyelocytic leukemia: clinical and morphologic features and prognostic factors. Semin Hematol 38:4-12
3. Avvisati G, Petti MC, Lo Coco F, Vegna ML, Amadori S, Baccarani M, Cantore N, Di Bona E, Ferrara F, Fioritoni G, Gallo E, Invernizzi R, Lazzarino M, Liso V, Mariani G, Ricciuti F, Selleri C, Sica S, Veneri D, Mandelli F, for GIMEMA (Gruppo Italiano Malattie Ematologische dell' Adulto) Italian Cooperative Group (2002) Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up. Blood 100:3141-3146
4. Birnie GD, MacKenzie ED, Goyns MH, Pollock A (1990) Sequestration of Philadelphia chromosome-positive cells in the bone marrow of a chronic myeloid leukemia patient in very prolonged remission. Leukemia 4:452-454
5. Fenaux P, Chevret S, Guerci A, Fegueux N, Dombret H, Thomas X, Sanz M, Link H, Maloisel F, Gardin C, Bordessoule D, Stoppa AM, Sadoun A, Muus P, Wandt H, Mineur P, Whittaker JA, Fey M, Daniel MT, Castaigne S, Degos L (2000) Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. Leukemia 14:1371-1377
6. Fenaux P, Chomienne C, Degos L (2001) All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. Semin Hematol 38:13-25
7. Ferrara F, Morabito F, Latagliata R, Martino B, Annunziata M, Oliva E, Schiavone EM, Pollio F, Palmieri S, Gianfaldoni G, Leoni F (2001) Aggressive salvage treatment is not appropriate for the majority of elderly patients with acute myeloid leukemia relapsed from first complete remission. Haematologica 86:814-80
8. Ferrara F, Del Vecchio L (2002) Acute myeloid leukemia with t(8;21)/AML1/ETO: a distinct biological and clinical entity. Haematologica 87:306-319
9. Latagliata R, Petti MC, Fenu S, Mancini M, Spiriti MA, Breccia M, Brunetti GA, Avvisati G, Lo Coco F, Mandelli F (2002) Therapy related myelodysplastic syndrome - acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem. Blood 99:822-824
10. Ohno R, Asou N, Ohnishi K (2003) Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate. Leukemia 17:1454-1463
11. Roberts WM, Estrov Z, Ouspenskaia MV, Johnston DA, McClain KL, Zipf TF (1997) Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. N Engl J Med 336:317-323
12. Sanz MA, Lo Coco F, Martin G, Avvisati G, Rayon C, Barbui T, Diaz-Mediavilla J, Fioritoni G, Gonzalez JD, Liso V, Esteve J, Ferrara F, Bolufer P, Bernasconi C, Gonzalez M, Rodeghiero F, Colomer D, Petti MC, Ribera JM, Mandelli F (2000) Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood 96:1247-1253
13. Slack JL, Gallagher RE (1999) The molecular biology of acute promyelocytic leukemia. Cancer Treat Res 99:75-124
14. Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Woods WG, Ogden A, Weinstein H, Shepherd L, Willman C, Bloomfield CD, Rowe JM, Wiernik PH (2002) All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. Blood 100:4298-4302